Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cervera

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Medicine|March 1, 1993
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus ErythematosusR Cervera, M A Khamashta, J Font, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
Autoimmunity Reviews|July 27, 2015
The role of infectious diseases in the catastrophic antiphospholipid syndromeM Garcia-Carrasco, C Mendoza-Pinto, S Macias-Diaz, et al.
Seminars in Arthritis and Rheumatism|January 6, 2000
Clinical study and follow-up of 100 patients with the antiphospholipid syndromeF J Muñoz-Rodriguez, J Font, R Cervera, et al.
Lupus|November 1, 1991
High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndromeR Cervera, M A Khamashta, J Font, et al.
BMJ (Clinical Research Ed.)|April 13, 1991
Antibodies to endothelial cells in dermatomyositis: association with interstitial lung diseaseR Cervera, G Ramírez, J Fernández-Solà, et al.
Molecular Psychiatry|July 8, 2015
MAOA expression predicts vulnerability for alcohol useR Cervera-Juanes, L J Wilhem, B Park, et al.
Autoimmunity Reviews|January 15, 2014
Patterns of systemic lupus erythematosus expression in EuropeR Cervera, A Doria, Z Amoura, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndromeR Cervera, J Font, J A Gómez-Puerta, et al.
Lupus|February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestationsR Cervera, M G Tektonidou, G Espinosa, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Medicine|March 1, 1993
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus ErythematosusR Cervera, M A Khamashta, J Font, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
Autoimmunity Reviews|July 27, 2015
The role of infectious diseases in the catastrophic antiphospholipid syndromeM Garcia-Carrasco, C Mendoza-Pinto, S Macias-Diaz, et al.
Seminars in Arthritis and Rheumatism|January 6, 2000
Clinical study and follow-up of 100 patients with the antiphospholipid syndromeF J Muñoz-Rodriguez, J Font, R Cervera, et al.
Lupus|November 1, 1991
High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndromeR Cervera, M A Khamashta, J Font, et al.
BMJ (Clinical Research Ed.)|April 13, 1991
Antibodies to endothelial cells in dermatomyositis: association with interstitial lung diseaseR Cervera, G Ramírez, J Fernández-Solà, et al.
Molecular Psychiatry|July 8, 2015
MAOA expression predicts vulnerability for alcohol useR Cervera-Juanes, L J Wilhem, B Park, et al.
Autoimmunity Reviews|January 15, 2014
Patterns of systemic lupus erythematosus expression in EuropeR Cervera, A Doria, Z Amoura, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndromeR Cervera, J Font, J A Gómez-Puerta, et al.
Lupus|February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestationsR Cervera, M G Tektonidou, G Espinosa, et al.
Pageof 33